How and where to order Gabapentin (Neurontin) 100 mg, 300 mg, 400 mg, 600 mg, 800 mg capsules or tablets online on Neurointerventions website:
|Prices:||from $0.45 per pill
|Discount:||10% coupon: DFHDCC
|Forms:||100 mg, 300 mg, 400 mg, 600 mg, 800 mg tablets or capsules
|Type:||Gabapentin brand, Neurontin generic
|Payment:||Visa, MasterCard, AmEx, E-Check (ACH), Bitcoin
|Delivery:||Regular airmail and express courier
|Shipping:||Worldwide, including USA, UK, Europe, Canada, Australia
Gabapentin (trade names include Neurontin, CO Gabapentin, Gabagamma, Gabapentin Actavis, Gabalept, Gabamox, Gabapentin Aurobindo, Gabexal, Gabictal, Gabapentin Hexal, Gabix, Gabapentin Ratiopharm, Vultin, Gabapentin Sandoz, Gabapentin Teva, Gabapentina Cinfa, Gabapentine EG, Gralise, Mylan-Gabapentin, Neurostil, Normatol, Novo-Gabapentin, Nupentin, PMS-Gabapentin, Tebantin, Teva-Gabapentin) is a medication from antiepileptics (anticonvulsants) pharmacological group. This medicine is effective in helping to control focal seizures, partial seizures (convulsions) in patients with epilepsy. It is also used to help relieve certain types of nerve pain, neuropathic pain caused by diabetic neuropathy, peripheral neuropathy, small fiber neuropathy, postherpetic neuralgia, occipital neuralgia, pudendal neuralgia, central pain, and for other nervous system disorders. Gabapentin is widely prescribed off-label for the treatment of non-neuropathic pain, fibromyalgia, erythromelalgia, bipolar disorder, anxiety disorders, restless legs syndrome, essential or orthostatic tremor, burning mouth syndrome, carpal tunnel syndrome, cluster-tic syndrome, cough, hiccups, chemotherapy induced nausea and vomiting, hyperhidrosis, pruritus, reflex sympathetic dystrophy syndrome, spondylolisthesis, syringomyelia, transverse myelitis, trigeminal neuralgia, vulvodynia, Lhermitte's sign, migraine, periodic limb movement disorder, insomnia, sleep disorder in patients with medical illness, for reducing the symptoms of alcohol withdrawal and associated craving; as a first-line treatment of the acquired pendular nystagmus, torsional nystagmus, infantile nystagmus, postmenopausal symptoms, to decrease the frequency of hot flashes in both menopausal women and patients with breast cancer; to reduces spasticity in multiple sclerosis, to alleviate itching in kidney failure (uremic pruritus) and itching of other causes; in veterinary medicine. In recreational purposes in rather high doses gabapentin can induce euphoria, a sense of calm, a marijuana-like high, improved sociability, and reduced alcohol or cocaine cravings.
Pharmacological and medical categories:
Drugs for neuropathic pain
Gamma-aminobutyric acid analogs
Nootropics and neurotonics
Pain relief medications
Veterinary, pet meds
N - Nervous system
N03 - Antiepileptics
N03A - Antiepileptics
N03AX - Other antiepileptics
N03AX12 - Gabapentin
Zoster [herpes zoster] - B02
Postherpetic polyneuropathy - B02.23
Malignant neoplasm of breast - C50
Type 2 diabetes mellitus - E11
Type 2 diabetes mellitus with diabetic neuropathy, unspecified - E11.40
Alcohol related disorders - F10
Alcohol dependence with withdrawal - F10.23
Bipolar disorder - F31
Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders - F40-F48
Other extrapyramidal and movement disorders - G25
Essential tremor - G25.0
Other specified forms of tremor - G25.2
Restless legs syndrome - G25.81
Multiple sclerosis - G35
Other demyelinating diseases of central nervous system - G37
Acute transverse myelitis in demyelinating disease of central nervous system - G37.3
Epilepsy and recurrent seizures - G40
Migraine - G43
Other headache syndromes - G44
Cluster headache syndrome, unspecified - G44.00
Sleep disorders - G47
Insomnia - G47.0
Periodic limb movement disorder - G47.61
Disorders of trigeminal nerve - G50
Trigeminal neuralgia - G50.0
Mononeuropathies of upper limb - G56
Carpal tunnel syndrome - G56.0
Other mononeuropathies - G58
Other specified mononeuropathies - G58.8
Hereditary and idiopathic neuropathy - G60
Other hereditary and idiopathic neuropathies - G60.8
Hemiplegia and hemiparesis - G81
Pain, not elsewhere classified - G89
Central pain syndrome - G89.0
Disorders of autonomic nervous system - G90
Complex regional pain syndrome I (CRPS I) - G90.5
Other idiopathic peripheral autonomic neuropathy - G90.09
Other and unspecified diseases of spinal cord - G95
Syringomyelia and syringobulbia - G95.0
Nystagmus and other irregular eye movements - H55
Unspecified nystagmus - H55.00
Other forms of nystagmus - H55.09
Other peripheral vascular diseases - I73
Erythromelalgia - I73.81
Diseases of tongue - K14
Glossodynia - K14.6
Pruritus - L29
Other pruritus - L29.8
Other deforming dorsopathies - M43
Spondylolisthesis - M43.1
Dorsalgia - M54
Occipital neuralgia - M54.81
Other soft tissue disorders, not elsewhere classified - M79
Neuralgia and neuritis, unspecified - M79.2
Fibromyalgia - M79.7
Pain and other conditions associated with female genital organs and menstrual cycle - N94
Vulvodynia - N94.81
Menopausal and other perimenopausal disorders - N95
Menopausal and female climacteric states - N95.1
Cough - R05
Abnormalities of breathing - R06
Hiccough - R06.6
Nausea and vomiting - R11
Other symptoms and signs involving the nervous and musculoskeletal systems - R29
Other symptoms and signs involving the nervous system - R29.818
Pain, not elsewhere classified - R52
Generalized hyperhidrosis - R61
Indications and usage:
Neurontin (Gabapentin) is indicated for:
Postherpetic neuralgia in adults.
Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy.
Dosage and administration:
Dose can be titrated up as needed to a dose of 1800 mg/day.
Day 1: Single 300 mg dose.
Day 2: 600 mg/day (i.e., 300 mg two times a day).
Day 3: 900 mg/day (i.e., 300 mg three times a day).
Epilepsy with partial onset seizures
Patients 12 years of age and older: starting dose of gabapentin is 300 mg three times daily; may be titrated up to 600 mg three times daily.
Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days.
Gabapentin dose should be adjusted in patients with reduced renal function.
Dosage forms and strengths:
Neurontin (Gabapentin) capsules: 100 mg, 300 mg, and 400 mg.
Neurontin (Gabapentin) tablets: 600 mg, and 800 mg.
Neurontin (Gabapentin) oral solution: 250 mg / 5 ml.
Signs of acute toxicity in animals included ataxia, labored breathing, ptosis, sedation, hypoactivity, or excitation.
Acute oral overdoses of gabapentin have been reported. Symptoms have included double vision, tremor, slurred speech, drowsiness, altered mental status, dizziness, lethargy, and diarrhea. Fatal respiratory depression has been reported with Neurontin overdose, alone and in combination with other CNS depressants.
Gabapentin can be removed by hemodialysis.
Known hypersensitivity to gabapentin or ingredients of its pharmaceutical forms.
Warnings and precautions:
Drug reaction with eosinophilia and systemic symptoms (multiorgan hypersensitivity): discontinue gabapentin if alternative etiology is not established.
anaphylaxis and angioedema: discontinue and evaluate patient immediately.
Driving impairment; somnolence/sedation and dizziness: warn patients not to drive until they have gained sufficient experience to assess whether their ability to drive or operate heavy machinery will be impaired.
Increased seizure frequency may occur in patients with seizure disorders if Neurontin is abruptly discontinued.
Suicidal behavior and ideation: monitor for suicidal thoughts/behavior.
Respiratory depression: may occur with Gabapentin (Neurontin) when used with concomitant central nervous system (CNS) depressants, including opioids, or in the setting of underlying respiratory impairment. Monitor patients and adjust dosage as appropriate.
Neuropsychiatric adverse reactions in children 3 to 12 years of age: monitor for such events.
Side effects, adverse reactions:
Most common adverse reactions of gabapentin (incidence >= 8% and at least twice that for placebo) were:
Postherpetic neuralgia: dizziness, somnolence, and peripheral edema.
Epilepsy in patients > 12 years of age: somnolence, dizziness, ataxia, fatigue, and nystagmus.
Epilepsy in patients 3 to 12 years of age: viral infection, fever, nausea and/or vomiting, somnolence, and hostility.
To report suspected adverse reactions, contact Pfizer Inc. or your local FDA.
Concentrations increased by morphine; may need dose adjustment.
Use in specific populations:
Based on animal data, may cause fetal harm.
Patient counseling information:
Inform patients that Neurontin (Gabapentin) is taken orally with or without food. Inform patients that, should they divide the scored 600 mg or 800 mg tablet in order to administer a half-tablet, they should take the unused half-tablet as the next dose. Advise patients to discard half-tablets not used within 28 days of dividing the scored tablet.
Drug reaction with eosinophilia and systemic symptoms (DRESS)/multiorgan hypersensitivity
Prior to initiation of treatment with gabapentin, instruct patients that a rash or other signs or symptoms of hypersensitivity (such as fever or lymphadenopathy) may herald a serious medical event and that the patient should report any such occurrence to a physician immediately.
Anaphylaxis and angioedema
Advise patients to discontinue Neurontin and seek medical care if they develop signs or symptoms of anaphylaxis or angioedema.
Dizziness and somnolence and effects on driving and operating heavy machinery
Advise patients that Gabapentin (Neurontin) may cause dizziness, somnolence, and other symptoms and signs of CNS depression. Other drugs with sedative properties may increase these symptoms. Accordingly, although patients' ability to determine their level of impairment can be unreliable, advise them neither to drive a car nor to operate other complex machinery until they have gained sufficient experience on Neurontin to gauge whether or not it affects their mental and/or motor performance adversely. Inform patients that it is not known how long this effect lasts.
Suicidal thinking and behavior
Counsel the patient, their caregivers, and families that AEDs, including gabapentin, may increase the risk of suicidal thoughts and behavior. Advise patients of the need to be alert for the emergence or worsening of symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts, behavior, or thoughts about self-harm. Instruct patients to report behaviors of concern immediately to healthcare providers.
Inform patients about the risk of respiratory depression. Include information that the risk is greatest for those using concomitant CNS depressants (such as opioid analgesics) or those with underlying respiratory impairment. Teach patients how to recognize respiratory depression and advise them to seek medical attention immediately if it occurs.
Use in pregnancy
Instruct patients to notify their physician if they become pregnant or intend to become pregnant during therapy, and to notify their physician if they are breast feeding or intend to breast feed during therapy.
Encourage patients to enroll in the NAAED Pregnancy Registry if they become pregnant. This registry is collecting information about the safety of antiepileptic drugs during pregnancy.
B1 - Australia
C - United States (Risk cannot be ruled out)
Salts and other forms:
Synonyms, international and chemical names:
Cyclohexaneacetic Acid, 1-(Aminomethyl)-
Brands, generics, trade names:
Apo-Gabapentin - Apotex, Hind Wing, Pharmaforte
Blugat - Landsteiner Scientific
CO Gabapentin - Cobalt Pharmaceuticals
Dineurin - Drugtech Laboratorio, Recalcine Laboratorios
Gabagamma - Worwag Pharma, Artesan Pharma
Gabalept - Micro Labs, Brown & Burk Pharmaceuticals, Synapse Medical
Gabamox - Pentafarma
Gabaneurin - EMS Industria Farmaceutica
Gabapentin - Accord Healthcare, Actavis, Aurobindo, Hexal, Mepha, Mylan, Ratiopharm, Sandoz, Teva
Gabapentina - Cinfa Laboratorios, Generis Farmaceutica, Normon Laboratorios, Pfizer, Stada, Teva
Gabapentine - Arrow Generiques, Biogaran, EG Labo, Mylan, Sandoz, Sanofi-Aventis, Teva, Zentiva
Gabapin-SR - Intas Pharmaceuticals
Gabastar - Lupin Laboratories
Gabatal - F. Joh. Kwizda
GabaTeva - Teva, Med Ilac
Gabator - Torrent Pharmaceuticals
Gabatrex - Intas Pharmaceuticals, Singapore Genebio
Gabatur - Cantabria Industrial Farmaceutica
Gabexal - Sandoz, Hexal
Gabictal - Tecnofarma
Gabix - Getz Pharma
Gafen - Siegfried Laboratorios
Gapridol - Psicofarma Laboratorio
Gralise - Abbott, Depomed
Logistic - Craveri
Mylan-Gabapentin - Mylan
Neogab - Hilton Pharma
Neurontin - Pfizer, Parke-Davis
Neurostil - IVAX
Nopatic - Rayere Farmaceuticos
Normatol - Pfizer
Novo-Gabapentin - Novopharm
Nupentin - Alphapharm, Merck, Ranbaxy, Serono
Nyepzyl - Ultra Laboratorios
PMS-Gabapentin - Pharmascience, IDS Group, Pharmaniaga, Ranbaxy
Pro-Gabapentin - Pro Doc
Ran-Gabapentin - Ranbaxy
Regalden - Mavi Farmaceutica
Ritmenal - Instituto Sanitas
Rontin - Biolab, Biopharm Chemicals
Tebantin - Gedeon Richter
Teva-Gabapentin - Teva
Ultraneural - Raffo Laboratorios
Vultin - Unison Laboratories, Medline
APIs used in medicine in combinations with gabapentin:
Methylcobalamin (Vitamin B12)
Vitamin B6 (Pyridoxine Hydrochloride)
Here is a list of popular medications containing gabapentin as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:
|Trade name of the drug
||Pharmaceutical forms and doses
||Capsules; Oral; Gabapentin 100 mgCapsules; Oral; Gabapentin 300 mgCapsules; Oral; Gabapentin 400 mg
||Worwag PharmaArtesan Pharma
||Capsules; Oral; Gabapentin 100 mgCapsules; Oral; Gabapentin 300 mgCapsules; Oral; Gabapentin 400 mgTablets; Oral; Gabapentin 100 mgTablets; Oral; Gabapentin 300 mgTablets; Oral; Gabapentin 400 mg
||Micro LabsBrown & Burk PharmaceuticalsSynapse Medical
||Capsules; Oral; Gabapentin 100 mgCapsules; Oral; Gabapentin 300 mgCapsules; Oral; Gabapentin 400 mgTablets; Oral; Gabapentin 600 mg
||Tablets, Film-Coated; Oral; Gabapentin 300 mgTablets, Film-Coated; Oral; Gabapentin 600 mg
||Capsules; Oral; Gabapentin 100 mgCapsules; Oral; Gabapentin 300 mgCapsules; Oral; Gabapentin 400 mgTablets; Oral; Gabapentin 600 mgTablets; Oral; Gabapentin 800 mg
||Capsules; Oral; Gabapentin 100 mgCapsules; Oral; Gabapentin 300 mgCapsules; Oral; Gabapentin 400 mgCapsules; Oral; Gabapentin 800 mgSolution; Oral; Gabapentin 250 mg / 5 mlTablets, Film-Coated; Oral; Gabapentin 600 mgTablets, Film-Coated; Oral; Gabapentin 800 mgTablets; Oral; Gabapentin 600 mgTablets; Oral; Gabapentin 800 mg
||Capsules; Oral; Gabapentin 100 mgCapsules; Oral; Gabapentin 300 mgCapsules; Oral; Gabapentin 400 mg
||Capsules; Oral; Gabapentin 100 mgCapsules; Oral; Gabapentin 300 mgCapsules; Oral; Gabapentin 400 mgTablets, Film-Coated; Oral; Gabapentin 600 mgTablets, Film-Coated; Oral; Gabapentin 800 mg
Gabapentin main article on Wikipedia: https://en.wikipedia.org/wiki/Gabapentin
Gabapentin compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Gabapentin
Gabapentin medicine on DrugBank: https://go.drugbank.com/drugs/DB00996
Gabapentin FAQ on MedlinePlus (revised 05/15/2020): https://medlineplus.gov/druginfo/meds/a694007.html
Gabapentin Ranbaxy capsules drug label on DailyMed (revised March 3, 2014): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Neurontin (Gabapentin) capsules, film-coated tablets, solution drug label on DailyMed (revised December 28, 2020): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Gabapentin international drug names on Drugs.com: https://www.drugs.com/international/gabapentin.html
Gabapentin containing drugs on Drugs-About.com: https://drugs-about.com/ing/gabapentin.html
Gabapentin for sale on Pharma Doctor: https://pharma-doctor.com/gabapentin.html
Neurontin (Gabapentin) capsules, tablets, solution for oral use official prescribing information and medication guide from the U.S. FDA (revised 10/2017): https://www.accessdata.fda.gov/drugsatfda_docs/label/...
Neurontin (Gabapentin) capsules, tablets, solution for oral use prescribing information and medication guide from Pfizer pharmaceutical company (revised 12/2020): http://labeling.pfizer.com/ShowLabeling.aspx?id=630
Neurontin (Gabapentin) 100 mg, 300 mg, 400 mg, 600 mg, 800 mg capsules consumer medicine information from MedSafe (revised December 2020): https://www.medsafe.govt.nz/Consumers/CMI/n/neurontin.pdf
Nupentin (Gabapentin) capsules product information from The Therapeutic Goods Administration (revised 06/08/2019): https://www.ebs.tga.gov.au/ebs/picmi/...
Gralise (Gabapentin) tablets official website: https://www.gralise.com/
Neurontin (Gabapentin) 100 mg, 300 mg, 400 mg hard capsules, 600 mg and 800 mg film-coated tablets patient information leaflet from Medicines.org.uk (revised 05/2020): https://www.medicines.org.uk/emc/files/pil.158.pdf
Revised: March 2021